Lan Zhao to Osteoarthritis
This is a "connection" page, showing publications Lan Zhao has written about Osteoarthritis.
Connection Strength
2.903
-
CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis. Mol Ther. 2024 Aug 07; 32(8):2549-2562.
Score: 0.672
-
Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints. Nat Commun. 2024 Apr 15; 15(1):3225.
Score: 0.664
-
Loss of miR-204 and miR-211 shifts osteochondral balance and causes temporomandibular joint osteoarthritis. J Cell Physiol. 2023 Nov; 238(11):2668-2678.
Score: 0.638
-
Exploration of CRISPR/Cas9-based gene editing as therapy for osteoarthritis. Ann Rheum Dis. 2019 05; 78(5):676-682.
Score: 0.466
-
Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann Rheum Dis. 2020 05; 79(5):635-645.
Score: 0.125
-
The microRNAs miR-204 and miR-211 maintain joint homeostasis and protect against osteoarthritis progression. Nat Commun. 2019 06 28; 10(1):2876.
Score: 0.119
-
Growth factor signalling in osteoarthritis. Growth Factors. 2018 12; 36(5-6):187-195.
Score: 0.115
-
Deletion of Runx2 in Articular Chondrocytes Decelerates the Progression of DMM-Induced Osteoarthritis in Adult Mice. Sci Rep. 2017 05 24; 7(1):2371.
Score: 0.103